Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
Coronavirus,Coronavirus Vaccine,Pfizer,Children
From the Center
AllSides Media Bias Rating: Center
The Pfizer (PFE.N)/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Headline Roundup
Newly Declassified Docs Accuse Fauci of Lying About COVID Origins, Research Funding
June 22nd, 2026
News
Mass Kidnappings, Covid Contingencies, ICE Controversies: Stories You May Have Missed
Malayna J. Bizier
June 18th, 2026
Red Blue Translator
Anti-vaxxer